Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 46

Sort by

Sort Order Select

Journal Articles

Hemoglobin Changes during Long-Lasting Frontline Treatment with Tyrosine-Kinase Inhibitors in Patients with Chronic Myeloid Leukemia

Roberto Latagliata, Ida Carmosino, Ambra Di Veroli, Emilia Scalzulli, Gioia Colafigli, Maria Cristina Scamuffa, Alessio Di Prima, Cinzia De Gregoris, Sara Pepe, Marco Mancini, Giulio Trapè, Maurizio Martelli, Robin Foa, Massimo Breccia

Blood (2021) 138 (Supplement 1): 1486.

https://doi.org/10.1182/blood-2021-151220

Published: 2021

Journal Articles

Prognostic Impact of t(4;11)(q21;q23)/ KMT2A-AFF1 -Positivity in 926 BCR-ABL1 -Negative B-Lineage Acute Lymphoblastic Leukemia Patients Treated in Gimema Clinical Trials Since 1996

Alfonso Piciocchi, Monica Messina, Loredana Elia, Bs, Antonella Vitale, MD, Stefano Soddu, Anna Maria Testi, MD, Sabina Chiaretti, MD PhD, Marco Mancini, MD, Giorgina Specchia, MD, Antonio Spadano, MD, Mauro Krampera, Roberto Cairoli, MD, Francesco Di Raimondo, MD, Felicetto Ferrara, MD, Giuseppe Cimino, MD, Renato Bassan, MD, Paola Fazi, MD, Marco Vignetti, MD

Blood (2019) 134 (Supplement_1): 1469.

https://doi.org/10.1182/blood-2019-121977

Published: 2019

Journal Articles

Clinical and Prognostic Features of Essential Thrombocythemia: Comparison of Who 2001 Versus Who 2008/2016 Criteria in a Large Single Center Cohort

Blood (2018) 132 (Supplement 1): 5464.

https://doi.org/10.1182/blood-2018-99-117905

Published: 2018

Journal Articles

Myelodysplastic Syndromes with Isolated 20q Deletion: A New Clinical-Biological Entity?

Daniela De Benedittis, MD, Luana Fianchi, MD, Pasquale Niscola, MD PhD, Annalina Piccioni, MD, Ambra Di Veroli, MD, Alessia Campagna, MD, Stefano Mancini, MD, Nicoletta Villivà, Sara Mohamed, MD, Ida Carmosino, Marianna Criscuolo, Susanna Fenu, Maria Antonietta Aloe Spiriti, MD, Francesco Buccisano, MD, Massimo Breccia, MD, Marco Mancini, Roberto Latagliata

Blood (2018) 132 (Supplement 1): 5516.

https://doi.org/10.1182/blood-2018-99-117069

Published: 2018

Journal Articles

Five Years after Frontline Tyrosine-Kinase Inhibitor (TKI) Treatment Initiation for Chronic Myeloid Leukemia: What Does It Happen in a Real-Life Setting?

Daniela De Benedittis, MD, Massimo Breccia, MD, Ida Carmosino, Elena Mariggiò, MD, Matteo Molica, MD, Sara Mohamed, MD, Fulvio Massaro, MD, Maria Lucia De Luca, MD, Emilia Scalzulli, MD, Chiara Lisi, MD, Mauro Passucci, MD, Gioia Colafigli, MD, Maria Giovanna Loglisci, MD, Daniela Diverio, Marco Mancini, Robin Foà, MD, Roberto Latagliata

Blood (2018) 132 (Supplement 1): 1746.

https://doi.org/10.1182/blood-2018-99-117272

Published: 2018

Journal Articles

The Impact of Cytogenetic Clonality on Outcomes in Younger Acute Myeloid Leukemia Patients: Results on 1290 Patients Included in the EORTC/Gimema AML-10 and AML-12 Trials

Blood (2017) 130 (Supplement 1): 1385.

https://doi.org/10.1182/blood.V130.Suppl_1.1385.1385

Published: 2017

Journal Articles

Does Bone Marrow Fibrosis Play a Role in the Prognostication of Newly Diagnosed Polycythemia Vera Patients?

Matteo Molica, MD, Daniela De Benedictis, MD, Emilia Scalzulli, MD, Ida Carmosino, Laura Cesini, Marta Chisini, MD, Maria Lucia De Luca, MD, Fulvio Massaro, MD, Gioia Colafigli, MD, Marco Mancini, Stefania Trasarti, MD, Massimo Breccia, MD PhD, Robin Foa, MD, Roberto Latagliata

Blood (2017) 130 (Supplement 1): 4184.

https://doi.org/10.1182/blood.V130.Suppl_1.4184.4184

Published: 2017

Journal Articles

Impact of Induction Regimen and of Allogeneic Hematopoietic Cell Transplantation on the Outcome in Younger Adults Patients with Acute Myeloid Leukemia with a Monosomal Karyotype: Results from the EORTC/Gimema AML-10 and AML-12 Trials

Frederic Baron, MD PhD, Marian Stevens-Kroef, PhD, Giovanna Meloni, MD, Petra Muus, MD PhD, Jean-Pierre Marie, MD, Constantijn J.M. Halkes, MD PhD, Xavier Thomas, MD PhD, Radovan Vrhovac, MD PhD, Giorgina Specchia, MD, Francois Lefrere, Sr., MD, Simona Sica, Marco Mancini, MD, Adriano Venditti, MD, Anne Hagemeijer, MD, Joop H. Jansen, PhD, Sergio Amadori, MD, Theo de Witte, MD, Roelof Willemze, MD PhD, Stefan Suciu, PhD

Blood (2016) 128 (22): 2847.

https://doi.org/10.1182/blood.V128.22.2847.2847

Published: 2016

Journal Articles

Incidence of Severe (≤ 10g/dl) Chronic Anemia in Elderly Patients with Newly Diagnosed Chronic Myeloid Leukemia Treated with Imatinib and Role of Erythropoietin Therapy

Laura Cesini, MD, Ida Carmosino, Melissa Campanelli, MD, Massimo Breccia, MD, Maria Lucia De Luca, Gioia Colafigli, Matteo Molica, Fulvio Massaro, Federico Vozella, Daniela Diverio, PhD, Marco Mancini, MD, Giuliana Alimena, Roberto Latagliata, MD

Blood (2016) 128 (22): 1903.

https://doi.org/10.1182/blood.V128.22.1903.1903

Published: 2016

Journal Articles

Pulmonary Infections in Patients with Myelodysplastic Syndromes Receiving Azacytidine Treatment

Roberto Latagliata, MD, Pasquale Niscola, MD, Maria Antonietta Aloe Spiriti, MD, Ida Carmosino, Laura Cesini, MD, Chiara Sarlo, MD, Annalina Piccioni, MD, Alessia Campagna, MD, Maria Lucia De Luca, Federico Vozella, Melissa Campanelli, MD, Marco Mancini, MD, Massimo Breccia, MD, Giuseppe Avvisati, MD, Agostino Tafuri, MD, Paolo de Fabritiis, MD, Giuliana Alimena, MD, Corrado Girmenia, MD

Blood (2016) 128 (22): 5544.

https://doi.org/10.1182/blood.V128.22.5544.5544

Published: 2016

Journal Articles

Event-Free Survival According to Age in Patients with Chronic Myeloid Leukemia Receiving Imatinib Frontline: The Younger, the Later, the Worse?

Roberto Latagliata, Massimo Breccia, MD, Ida Carmosino, Federico Vozella, Federico De Angelis, Chiara Montagna, Maria Lucia De Luca, Gioia Colafigli, Luisa Quattrocchi, Giovanna Loglisci, Angela Romano, Paola Volpicelli, Daniela Diverio, PhD, Marco Mancini, Giuliana Alimena

Blood (2015) 126 (23): 4038.

https://doi.org/10.1182/blood.V126.23.4038.4038

Published: 2015

Journal Articles

Improved Overall Survival with Gemtuzumab Ozogamicin (GO) Compared with Best Supportive Care (BSC) in Elderly Patients with Untreated Acute Myeloid Leukemia (AML) Not Considered Fit for Intensive Chemotherapy: Final Results from the Randomized Phase III Study (AML-19) of the EORTC and Gimema Leukemia Groups

Blood (2014) 124 (21): 619.

https://doi.org/10.1182/blood.V124.21.619.619

Published: 2014

Journal Articles

Independent Prognostic Impact of CD15 for Achievement of Complete Remission in Patients with Acute Myeloid Leukemia

Blood (2014) 124 (21): 3687.

https://doi.org/10.1182/blood.V124.21.3687.3687

Published: 2014

Journal Articles

Acute Myeloid Leukemia Patients with an Undefined Genetic Profile at Diagnosis: Clinical and Prognostic Aspects

Blood (2014) 124 (21): 5326.

https://doi.org/10.1182/blood.V124.21.5326.5326

Published: 2014

Journal Articles

Role of CD133 As a Marker of Previous Myelodysplasia in De Novo Elderly Patients with Acute Myeloid Leukemia

Blood (2014) 124 (21): 1063.

https://doi.org/10.1182/blood.V124.21.1063.1063

Published: 2014

Journal Articles

Exclusion Criteria In The Dasision and Enestnd Trials: Which Could Their Impact Be On The Front-Line Treatment Of a “Real-life” Patient Population With Chronic Myelogenous Leukemia?

Roberto Latagliata, MD, Ida Carmosino, Federico Vozella, Paola Volpicelli, MD, Giuseppina Loglisci, Michelina Santopietro, Adriano Salaroli, MD, Angela Romano, Chiara Montagna, Amanda Roberto, Alessandra Serrao, Daniela Diverio, PhD, Mauro Nanni, PhD, Marco Mancini, Agostino Tafuri, Massimo Breccia, Giuliana Alimena, MD

Blood (2013) 122 (21): 4002.

https://doi.org/10.1182/blood.V122.21.4002.4002

Published: 2013

Journal Articles

Incidence of Late Chronic Anemia in Newly Diagnosed Patients with Chronic Myelogenous Leukemia Responsive to Imatinib

Paola Volpicelli, MD, Roberto Latagliata, MD, Massimo Breccia, Federico Vozella, Paola Finsinger, Ida Carmosino, Giuseppina Loglisci, MD, Michelina Santopietro, MD, Adriano Salaroli, Daniela Diverio, PhD, Marco Mancini, MD, Agostino Tafuri, Giuliana Alimena

Blood (2012) 120 (21): 3769.

https://doi.org/10.1182/blood.V120.21.3769.3769

Published: 2012

Journal Articles

Additional chromosomal abnormalities in Philadelphia-positive clone: adverse prognostic influence on frontline imatinib therapy: a GIMEMA Working Party on CML analysis

Blood (2012) 120 (4): 761–767.

https://doi.org/10.1182/blood-2011-10-384651

Published: 2012

Journal Articles

Polycombs and microRNA-223 regulate human granulopoiesis by transcriptional control of target gene expression

Giuseppe Zardo, Alberto Ciolfi, Laura Vian, Linda M. Starnes, Monia Billi, Serena Racanicchi, Carmen Maresca, Francesco Fazi, Lorena Travaglini, Nelida Noguera, Marco Mancini, Mauro Nanni, Giuseppe Cimino, Francesco Lo-Coco, Francesco Grignani, Clara Nervi

Blood (2012) 119 (17): 4034–4046.

https://doi.org/10.1182/blood-2011-08-371344

Published: 2012

Includes: Supplemental data

NARROW

Hemoglobin Changes during Long-Lasting Frontline Treatment with Tyrosine-Kinase Inhibitors in Patients with Chronic Myeloid Leukemia

Prognostic Impact of t(4;11)(q21;q23)/ KMT2A-AFF1 -Positivity in 926 BCR-ABL1 -Negative B-Lineage Acute Lymphoblastic Leukemia Patients Treated in Gimema Clinical Trials Since 1996

Clinical and Prognostic Features of Essential Thrombocythemia: Comparison of Who 2001 Versus Who 2008/2016 Criteria in a Large Single Center Cohort

Myelodysplastic Syndromes with Isolated 20q Deletion: A New Clinical-Biological Entity?

Five Years after Frontline Tyrosine-Kinase Inhibitor (TKI) Treatment Initiation for Chronic Myeloid Leukemia: What Does It Happen in a Real-Life Setting?

The Impact of Cytogenetic Clonality on Outcomes in Younger Acute Myeloid Leukemia Patients: Results on 1290 Patients Included in the EORTC/Gimema AML-10 and AML-12 Trials

Does Bone Marrow Fibrosis Play a Role in the Prognostication of Newly Diagnosed Polycythemia Vera Patients?

Impact of Induction Regimen and of Allogeneic Hematopoietic Cell Transplantation on the Outcome in Younger Adults Patients with Acute Myeloid Leukemia with a Monosomal Karyotype: Results from the EORTC/Gimema AML-10 and AML-12 Trials

Incidence of Severe (≤ 10g/dl) Chronic Anemia in Elderly Patients with Newly Diagnosed Chronic Myeloid Leukemia Treated with Imatinib and Role of Erythropoietin Therapy

Pulmonary Infections in Patients with Myelodysplastic Syndromes Receiving Azacytidine Treatment

Event-Free Survival According to Age in Patients with Chronic Myeloid Leukemia Receiving Imatinib Frontline: The Younger, the Later, the Worse?

Independent Prognostic Impact of CD15 for Achievement of Complete Remission in Patients with Acute Myeloid Leukemia

Acute Myeloid Leukemia Patients with an Undefined Genetic Profile at Diagnosis: Clinical and Prognostic Aspects

Role of CD133 As a Marker of Previous Myelodysplasia in De Novo Elderly Patients with Acute Myeloid Leukemia

Exclusion Criteria In The Dasision and Enestnd Trials: Which Could Their Impact Be On The Front-Line Treatment Of a “Real-life” Patient Population With Chronic Myelogenous Leukemia?

Whole Transcriptome Sequencing In Refractory T-Cell Acute Lymphoblastic Leukemia

Incidence of Late Chronic Anemia in Newly Diagnosed Patients with Chronic Myelogenous Leukemia Responsive to Imatinib

Additional chromosomal abnormalities in Philadelphia-positive clone: adverse prognostic influence on frontline imatinib therapy: a GIMEMA Working Party on CML analysis

Polycombs and microRNA-223 regulate human granulopoiesis by transcriptional control of target gene expression

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only